PAPP-A levels as an early marker of idiopathic preterm birth: A pilot study

Journal of Perinatology

Volumn 27, Issue 11, 2007, Pages 681-686

  Grisaru Granovsky, S ^a   Halevy, T ^a   Planer, D ^b   Elstein, D ^a   Eidelman, A ^a   Samueloff, A ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CALCIUM CHANNEL BLOCKING AGENT; INDOMETACIN; MAGNESIUM SULFATE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN A; SOMATOMEDIN C;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; PREDICTION; PREMATURE LABOR; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TOCOLYSIS;

ADULT; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LIKELIHOOD FUNCTIONS; OBSTETRIC LABOR, PREMATURE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; SOMATOMEDINS; TOCOLYSIS;

EID: 35648989970     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211800     Document Type: Article

References (29)

1. Herber-Jonat S, Schulze A, Kribs A, Roth B, Lindner W, Pohlandt F. Survival and major neonatal complications in infants born between 22 a/7 and 24 6/7 weeks of gestation (1999-2003). Am J Obstet Gynecol 2006; 195: 16-22.
2. Davidoff MJ, Dias T, Damus K, Russell R, Bettegowda VR, Dolan S et al. Changes in the gestational age distribution among US singleton births: Impact on rates of late preterm birth, 1992-2002. Semin Perinatol 2006; 30: 8-15.
3. Amitai Y, Haklai Z, Tarabeia J, Green MS, Rotem N, Fleisher E et al. Infant mortality in Israel during 1950-2000: Rates, causes, demographic characteristics and trends Erratum in: Paediatr Perinat Epidemiol. 2005;19:351 Peadiatr Perinat Fpidemiol 2005; 19: 145-151.
4. Martin JA, Hamilton BE; Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: Final data for 2003. Natl Vital Stat Rep 2005; 54: 1-116.
5. Merlob P, Sapir O, Sulkes J, Fisch B. The prevalence of major congenital malformations during two periods of time, 1986-1994 and 1995-2002 in newborns conceived by assisted reproduction technology. Eur J Med Genet 2005; 48: 5-11.
6. Nicholson WK, Frick KD, Powe NR. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol 2000; 96: 95-101.
7. Petrou S, Mehta 4 Hockley C, Cook-Mozaffari P, Henderson J, Goldacre M. The impact of preterm birth on hospital inpatient admissions and costs during first 5 years of life. Pediatrics, 2003; 112(Part 1 : 1290-1297.
8. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002; 212: 778-782.
9. Hughes, G, Bischof P, Wilson G, Smith klopper A. Tests of fetal wellbeing in the third trimester of pregnancy. Br J Obstet Gynaecol 1980, 87: 650-656.
10. Westergaard JG, Teisner B, Han J, Grudzinskas JG. Placental proteín measurements in complicated pregnancies. III. Premature labour. Br J Obstét Gynaecol 1984; 91: 1230-1233.
11. Johnson MR, Riddle AF, Grudzikas JG, Sharma V, Collins WP, Nicolaides KH. Reduced circulating placental protein concentrations during the first trimester are associated with preterm labour and low birth weight. Hum Reprod 1993; 8: 1942-1947.
12. Smith GC,. Stenhouse EJ, Crossley JA Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-assodated plasma protein a and the risk of Intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-1767.
13. Kwik M, Morris J Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome. Aust N Z J Obstet Gynaecol 2003; 43: 438-442.
14. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, ComstOck CH et al. First trimester maternal serum PAPP-A and free-beta subunit human chorionic genadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004; 191: 1446-1451.
15. Ozer KT, Kavak ZN, Gokaslan H, Elter K, Pekin T. Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery. Eur J Obstet Gynecol Reprod Biol 2005;. 122: 187-190.
16. Lawrence JB, Oxvig C, Overgaard MT, Sothrup-Jensen L, Gleich GJ, Hays LG et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 ptotease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999, 96: 3149-3153.
17. Overgaard MT, Haaning J, Boldt HB, Olsen.IM, Laursen IS, Christiansen M el al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil-major basic protein as its physiological inhibitor. J Biol Chem 2000; 275: 31128-31133.
18. Giudice LC, Conover CA, Bale L, Faessen GH, Ilg K, Sun I et al. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 2002,87: 2359-2366.
19. Resch ZT, Chen BK, Bale LK Oxvig C, Overgaard MT, Conover CA Pregnancy associated plasma protein a gene expression as a target of inflammatory cytokines, Endocrinology. 2OD4; 145: 1124-1129.
20. Goffinet F, Maillard F, Fulla Y, Cabrol D. Biochemical markers (without markers of infection) of the risk of preterm delivery. Implications for clinical practice. Eur J Obstet Gynecol Reprod Biol 2001; 94 59- 68.
21. The American College of Obstetricians Gynecologists. Assessment of risk factors for preterm birth, ACOG Practice Bulletin No 31. Obstet Gynecol 2001; 98: 709-716.
22. Goldenberg RL, Goepfert AR, Ramsey PS. Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol 2005; 192: S36-46.
23. Mauldin JG, Newman RB. Preterm birth risk assessment. Semin Perinatol 2001; 25: 215-222.
24. Goffinet F. Primary predictors of preterm labour. BJOG 2005; 112(Suppl 1): 38-47.
25. Lowe MP, Zimmerman B, Hansen W. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center. Am J Obstet Gynecol 2004; 190: 358-362.
26. Vogel I, Thorsen P, Curry A, Sandager P, Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand 2005; 84: 516-525.
27. Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second trimester amniotic fluid interleukin-6 predict preterm delivery. Am J Obstet Gynecol 1998; 178: 546-550.
28. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Luckes A, Iams JD et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 1997; 177: 13-18.
29. Di Renzo GC, Roura LC, the European Association of Perinatal Medicine-Study group on 'PretermBirth'. Guidelines for the management of spontaneous preterm labor. J Perinat Med 2006; 34: 359-366.